We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
KRT17
  • premium

    TISSUE

  • premium

    CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

KRT17

Gene description

Keratin 17, type I

Protein class

Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

5
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Group enriched (hTCEpi, SiHa)
HPA (normal tissue):Tissue enhanced (breast, seminal vesicle, urinary bladder)

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Selective cytoplasmic and membranous expression mainly in squamous epithelia, urinary bladder, salivary gland, breast, prostate and respiratory tract.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining mainly consistent with RNA expression data. Caution, targets protein from more than one gene.

Reliability score

Supported based on 4 antibodies.
HPA000452 , HPA000453 , HPA045062 , CAB000029
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in breast cancer (favourable) and renal cancer (unfavourable).
Breast cancer p<0.001
Renal cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Skin cancer

STAINING SUMMARY

HPA000452
HPA000453
HPA045062
CAB000029

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Strong and distinct cytoplasmic and membranous positivity in a varying fraction of all carcinoma types. Melanomas, gliomas, lymphomas and renal clear cell carcinomas were negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most cancer tissues showed moderate to strong cytoplasmic and membranous positivity. Gliomas, lymphomas, testis renal and liver cancers were generally negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Majority of the cases of cervical, skin, urothelial, lung, head and neck cancers along with few cases of ovarian, pancreatic and liver cancers displayed strong cytoplasmic staining with additional membranous positivity in several cases. Remaining cancer tissues were generally negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

A majority of skin, urothelial, cervical, lung, pancreatic and head and neck cancers displayed moderate to strong cytoplasmic and membranous positivity. Additionally, a few cases of breast, ovary and thyroid cancer were moderately stained. Remaining cancer tissues were weakly stained or negative.

GENE INFORMATION

Gene name

KRT17 (HGNC Symbol)

Synonyms

PCHC1

Description

Keratin 17, type I (HGNC Symbol)

Entrez gene summary

This gene encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex. [provided by RefSeq, Aug 2008]

Chromosome

17

Cytoband

q21.2

Chromosome location (bp)

41619437 - 41624842

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000128422 (version 83.38)

Entrez gene

3872

UniProt

Q04695 (UniProt - Evidence at protein level)

neXtProt

NX_Q04695

Antibodypedia

KRT17 antibodies

PROTEIN BROWSER

KRT17-001
KRT17-002
KRT17-005
KRT17-006
KRT17-201

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

KRT17-001
ENSP00000308452
ENST00000311208
Q04695 [Direct mapping]
Keratin, type I cytoskeletal 17
Show all
Predicted intracellular proteins
Plasma proteins
Cancer-related genes
   Candidate cancer biomarkers
Disease related genes
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002009 [morphogenesis of an epithelium]
GO:0005198 [structural molecule activity]
GO:0005200 [structural constituent of cytoskeleton]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005882 [intermediate filament]
GO:0007165 [signal transduction]
GO:0008544 [epidermis development]
GO:0030307 [positive regulation of cell growth]
GO:0031069 [hair follicle morphogenesis]
GO:0031424 [keratinization]
GO:0032395 [MHC class II receptor activity]
GO:0042289 [MHC class II protein binding]
GO:0045109 [intermediate filament organization]
GO:0045727 [positive regulation of translation]
GO:0051798 [positive regulation of hair follicle development]
GO:0070062 [extracellular exosome]
GO:0071944 [cell periphery]
Show all
432 aa
48.1 kDa
No 0
KRT17-002
ENSP00000468672
ENST00000463128
K7ESE1 [Direct mapping]
Keratin, type I cytoskeletal 17
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005198 [structural molecule activity]
GO:0005882 [intermediate filament]
Show all
95 aa
11 kDa
No 0
KRT17-005
ENSP00000467418
ENST00000577817
K7EPJ9 [Direct mapping]
Keratin, type I cytoskeletal 17
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005198 [structural molecule activity]
GO:0005882 [intermediate filament]
Show all
231 aa
24.9 kDa
No 0
KRT17-006
ENSP00000466166
ENST00000590038
K7ELP7 [Direct mapping]
Keratin, type I cytoskeletal 17
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005198 [structural molecule activity]
GO:0005882 [intermediate filament]
Show all
49 aa
5.5 kDa
No 0
KRT17-201
ENSP00000441751
ENST00000540235
F5GWP8 [Direct mapping]
Keratin, type I cytoskeletal 17
Show all
   SPOCTOPUS predicted secreted proteins
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005198 [structural molecule activity]
GO:0005515 [protein binding]
GO:0005882 [intermediate filament]
Show all
349 aa
40.3 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.